Tag: #Global Trends

On April 23, 2026, the US Food and Drug Administration (FDA) authorized Otarmeni (lunsotogene parvec-cwha), the first-ever gene therapy for... Read more

The United States Food and Drug Administration (FDA) has granted approval for icotrokinra, marketed under the brand name ICOTYDE, as... Read more

Plus Therapeutics has begun technology transfer and manufacturing activities at SpectronRx to support late-stage clinical production of Rhenium-186 and Reyobiq... Read more

Regeneron Pharmaceuticals has become the 17th major drugmaker to reach a pricing agreement with the Trump administration. Under the "Most... Read more

The European Medicines Agency (EMA) has issued a positive recommendation for tolebrutinib, Sanofi’s experimental treatment for multiple sclerosis (MS). This... Read more

The World Health Organization (WHO) has officially prequalified Coartem® Baby (artemether-lumefantrine), marking the arrival of the first antimalarial drug specifically... Read more

Sanofi has kicked off 2026 with a strong first-quarter performance, reporting revenues of over €10.5 billion, a 13.6% increase at... Read more

Roche has reported its first-quarter revenues for 2026, revealing a 5% decline in reported sales to CHF 14.77 billion. However,... Read more

UK Biobank has reported a significant security lapse following the discovery of "de-identified" records from 500,000 participants listed for sale... Read more